STOCK TITAN

Nutex Health Schedules 2026 Second Quarter Financial Results Release and Conference Call

(Moderate)
(Neutral)
Tags
conferences earnings date

Nutex Health (NASDAQ: NUTX) plans to file its Form 10-Q for the second quarter ended June 30, 2026, on Thursday, Aug. 6, 2026, after market close, and issue a financial results release the same day.

The company will host an earnings conference call on Friday, Aug. 7, 2026, at 9:30 a.m. CT, with participant dial-in numbers and a Call me™ link provided, and will later post a transcript and recording under “Investor Materials” on its website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market reaction after 2Q26 earnings report: NUTX +4.21% in the Jul 21 session

+4.21%
9 alerts
+4.21% Session close to close
-7.4% Trough in 29 hr 33 min
$1.12B Market Cap
0.6x Rel. Volume

In the Jul 21 session, NUTX gained 4.21%, reflecting a moderate positive market reaction. Argus tracked a trough of -7.4% from its starting point during tracking. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The five matching schedule announcements averaged -0.11% over 24 hours, adding a historical baseline...
Analysis

The five matching schedule announcements averaged -0.11% over 24 hours, adding a historical baseline to this release date. The eventual filing and conference call remain the substantive checkpoints; moderate short positioning is a sourced risk factor.

Key Figures

Operating footprint: 27 micro hospitals States of operation: 12 states Fiscal quarter end: June 30, 2026 +3 more
6 metrics
Operating footprint 27 micro hospitals 12 states
States of operation 12 states Company operating footprint
Fiscal quarter end June 30, 2026 Second fiscal quarter
Form 10-Q filing date Aug. 6, 2026 Second fiscal quarter, after market close
Financial results release Aug. 6, 2026 Corresponding press release issued the same day
Earnings conference call Aug. 7, 2026 at 9:30 a.m. CT Discussion of financial performance and business update

Previous Conferences,earnings date Reports

5 past events · Latest: Apr 22 (Neutral)
Same Type Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Apr 22 Q1 results scheduling Neutral +0.8% Q1 2026 results release and conference call dates were announced.
Feb 25 Year-end scheduling Neutral +6.7% Q4 and year-end 2025 results release and conference call dates were announced.
Aug 08 Q2 results scheduling Neutral -1.5% Q2 2025 results release and conference call dates were announced.
May 07 Q1 results scheduling Neutral -11.6% Q1 2025 results release and conference call dates were announced.
Mar 17 Year-end scheduling Neutral +5.0% Q4 and full-year 2024 results release and conference call dates were announced.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Matching scheduling announcements showed mixed 24-hour reactions and an average move of -0.11%.

Key Terms

form 10-q
1 terms
form 10-q regulatory
"plans to file its Form 10-Q for the second fiscal quarter"
A Form 10-Q is a detailed report that publicly traded companies are required to file with regulators three times a year, providing an update on their financial health and business activities. It is important for investors because it offers timely insights into a company's performance, helping them make informed decisions about buying or selling stocks. Think of it as a regular check-up report that shows how well a company is doing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

HOUSTON, July 21, 2026 /PRNewswire/ — Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Form 10-Q for the second fiscal quarter ended June 30, 2026, on Thursday, Aug. 6, 2026, after the market close. The Company will also issue a corresponding press release summarizing financial results on the same day.

Nutex Health will host its earnings conference call on Friday, Aug. 7, 2026, at 9:30 a.m. CT to discuss the Company's financial performance and provide a business update.

Conference Call Details

Date: Friday, Aug. 7, 2026
Time: 9:30 a.m. CT
Participant Listening: 1-877-407-9208 or 1-201-493-6784

Call me™:
https://callme.viavid.com/viavid/?callme=true&passcode=13746493&h=true&info=company&r=true&B=6

Participants can use the guest dial-in numbers above to join the call through an operator or click the Call me™ link for immediate telephone access to the event.

  • The Call me™ link will be made active 15 minutes prior to the scheduled start time.

Following the event, a transcript and recording of the call will be available on the Company's website under the "Investor Materials" section.

About Nutex Health Inc.

Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with three divisions: a Hospital Division, Population Health Management Division, and Real Estate Division

The Hospital Division owns, develops, and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 27 facilities in 12 states.

The Population Health Management division owns and operates provider networks such as Independent Physician Associations. Through our Management Services Organization, we provide management, administrative and other support services to our affiliated hospitals and physician groups.

The real estate division comprises of real estate entities along with activity related to the development and construction of hospital facilities. The real estate entities own the land and hospital buildings which are leased to our hospital entities.

Forward-Looking Statements

Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words or phrases "will," "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act, to remediate our material weaknesses in a timely manner, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent Quarterly Report on Form 10-Q for the three months ended March 31, 2026 under the heading "Risk Factors" in Part II, Item IA thereof, and the risk factors and other cautionary statements contained in our other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.

Cision View original content:https://www.prnewswire.com/news-releases/nutex-health-schedules-2026-second-quarter-financial-results-release-and-conference-call-302830277.html

SOURCE Nutex Health, Inc.

FAQ

When will Nutex Health (NUTX) release its Q2 2026 financial results?

Nutex Health plans to file its Form 10-Q and release second quarter 2026 financial results on Thursday, Aug. 6, 2026, after the market close. According to Nutex Health, the filing covers the quarter ended June 30, 2026.

When is the Nutex Health (NUTX) Q2 2026 earnings conference call scheduled?

The Nutex Health Q2 2026 earnings conference call is scheduled for Friday, Aug. 7, 2026, at 9:30 a.m. CT. According to Nutex Health, management will discuss financial performance and provide a business update on that call.

How can investors join the Nutex Health (NUTX) Q2 2026 earnings call by phone?

Investors can join the Nutex Health earnings call by dialing 1-877-407-9208 or 1-201-493-6784. According to Nutex Health, participants may also use the Call me™ link for immediate operator-assisted telephone access.

Will a replay of the Nutex Health (NUTX) Q2 2026 earnings call be available for investors?

Yes, a transcript and recording of the Nutex Health Q2 2026 earnings call will be available after the event. According to Nutex Health, these materials will be posted under the “Investor Materials” section of the company’s website.